Abiopharma

News list

Lowell Matthew 🟢 acquired 211.0K shares (1 derivative) of Alpha Teknova, Inc. (TKNO) at $2.19 Transaction Date: Feb 15, 2026 | Filing ID: 000002

Full text

News bot March 9, 2026, 8:31 p.m.
🔍 Lowell Matthew (Executive)

Company: Alpha Teknova, Inc. (TKNO)

Report Date: 2026-02-15
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 211,000
Detailed Transactions and Holdings:
- Acquired 40,000 shares of Common Stock at $2.1904 per share (Direct)
  Date: 2026-03-06 | Code: P | equity_swap_involved: 0 | shares_owned_after: 168,376.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 171,000 shares of Non-Qualified Stock Option (right to buy) at $1.99 per share (Derivative)
  Date: 2026-02-15 | Code: A | Expires: 2036-02-15 | equity_swap_involved: 0 | shares_owned_after: 171,000.00 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.13 to $2.20, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Footnote to this Form 4.
- F2: The number of shares subject to the option shall vest in 48 equal monthly installments on the same day of each month after February 15, 2026, the date of grant.